深交所向上海凯利泰医疗科技股份有限公司及相关当事人发出监管函

Group 1 - The Shenzhen Stock Exchange issued a regulatory letter to Shanghai Kellytech Medical Technology Co., Ltd. regarding violations related to undisclosed related party transactions with Shanghai Zhengbairui Medical Devices Co., Ltd. from 2021 to 2023 [1] - The company and its executives, including former Chairman Yuan Zheng, former Director and General Manager Wang Zhengmin, and former Board Secretary Ding Kui, failed to fulfill their duties of diligence and integrity, violating the listing rules [1] - The company is required to take corrective actions and ensure that similar issues do not occur in the future [1] Group 2 - As of the report, the market capitalization of ST Kellytech is 4.2 billion yuan [2] - The A-share market has surpassed 4,000 points, indicating a significant market resurgence after a decade of stagnation, with a new "slow bull" market pattern emerging [2]